Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy Controls

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

June 30, 2013

Conditions
Postherpetic NeuralgiaHealthy Age/Gender Matched Volunteers
Interventions
OTHER

skin biopsy

Using a punch biopsy, the study doctor will take a small sample of skin (3mm diameter) from a pre-defined site of the subject. For PHN patients, 4 biopsies will be obtained: 2 in an area of PHN and 2 in a contralateral control site. Biopsy sites for each PHN control subject will be matched anatomically to the corresponding PHN patient with two biopsies each from symmetrical sites in a left and right dermatome. One biopsy from each site in each subject will be fixed in a left and right dermatome. One biopsy from each site in each subject will fixed yb immersion in 4% paraformaldehyde for immunocytochemical analysis, and the second biopsy form each site will be flash frozen for assessments of mRNA expression.

Trial Locations (1)

12208

Albany Medical College, Albany

Sponsors
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Albany Medical College

OTHER

NCT01379716 - Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy Controls | Biotech Hunter | Biotech Hunter